SCHEMBL462297

SCHEMBL462297

[1C]OCc1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11798054 0.77
Benzene SCHEMBL27359414 0.77 TSHR (0.60)
SCHEMBL393607 0.77
SCHEMBL5311581 0.75 TSHR (1.00)
SCHEMBL27380 0.75 TSHR (1.00)
SCHEMBL177923 0.75 TSHR (0.67)
Benzene SCHEMBL27997624 0.75 TSHR (1.00)
SCHEMBL723193 0.74 TSHR (0.57)
Methane SCHEMBL11192510 0.73 TSHR (0.94)
SCHEMBL10317949 0.73 TSHR (0.94)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6573367-B1 Preparation using benzyloxycarbonyl chloride, sodium hydrogen carbonate and benzene; methylation, hydrogenolysis PLIVA, FARMACEUTSKA INDUSTRIJA, DIONICKO DRUSTVO (HR) 2003-06-03 US claimed
EP-3110799-A1 HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL Epirus Biopharmaceuticals, Inc. (US) 2017-01-04 EP disclosed
WO-2015127549-A1 HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL PAJOUHESH HASSAN (CA) 2015-09-03 WO disclosed
WO-2012033956-A1 COGNITION ENHANCING COMPOUNDS AND COMPOSITIONS, METHODS OF MAKING, AND METHODS OF TREATING MITHRIDION, INC. (US) 2012-03-15 WO disclosed
EP-0800528-A1 PEPTIDE AND PEPTIDE ANALOG PROTEASE INHIBITORS Sibia Neurosciences, Inc. (US) 1997-10-15 EP disclosed
WO-1996020949-A1 PEPTIDE AND PEPTIDE ANALOG PROTEASE INHIBITORS SIBIA NEUROSCIENCES, INC. (US) 1996-07-11 WO disclosed